Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dunlei Cheng

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Pharmacoepidemiology and Drug Safety|February 26, 2013
Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs on the development of chronic kidney diseaseAndrew L Masica, Edward Ewen, Yahya A Daoud, et al.
American Journal of Hematology|May 2, 2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn M Malec, Dunlei Cheng, Char M Witmer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophiliaStacy E Croteau, Dunlei Cheng, Alice J Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Blood Advances|June 14, 2018
A cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L Sood, Dunlei Cheng, Margaret Ragni, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Pharmacoepidemiology and Drug Safety|February 26, 2013
Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs on the development of chronic kidney diseaseAndrew L Masica, Edward Ewen, Yahya A Daoud, et al.
American Journal of Hematology|May 2, 2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn M Malec, Dunlei Cheng, Char M Witmer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophiliaStacy E Croteau, Dunlei Cheng, Alice J Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Blood Advances|June 14, 2018
A cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L Sood, Dunlei Cheng, Margaret Ragni, et al.
Pageof 5